College of Pharmacy and Bio-MAX Institute, Seoul National University, Seoul, Korea.
Department of Pathology, Integrated Genomic Research Center for Metabolic Regulation, Yonsei University College of Medicine, Seoul, Korea.
Oncogene. 2016 Oct 13;35(41):5435-5445. doi: 10.1038/onc.2016.82. Epub 2016 Apr 4.
Hepatitis B virus X protein (HBx) contributes to the development of hepatocellular carcinoma (HCC), probably by regulating activities of many host or viral proteins through protein-protein interactions. In this study, we identified poly(ADP-ribose) polymerase (PARP1), a crucial factor in DNA repair, as an HBx-interacting protein using a proteomics approach. Coimmunoprecipitation and proximity ligation assays confirmed the binding and colocalization of HBx and PARP1 in the nucleus. The carboxyl-terminus of HBx protein bound to the catalytic domain of PARP1, and this binding reduced the enzymatic activity of PARP1 in both in vitro and in vivo assays. HBx interrupted the binding of PARP1 to Sirt6, which catalyzes the mono-ADP-ribosylation required for DNA repair. Consistently, overexpression of HBx inhibited the clearance of γH2AX DNA repair foci generated under oxidative stress in Chang liver cells. Recruitment of the DNA repair complex to the site-specific double-strand breaks was inhibited in the presence of HBx, when measured by laser microirradiation assay and damage-specific chromatin immunoprecipitation assays. Consequently, HBx increased signs of DNA damage such as accumulation of 8-hydroxy-2'-deoxyguanosine and comet formation, which were reversed by overexpression of PARP1 and/or Sirt6. Finally, the interaction between PARP1 and Sirt6 was markedly lower in the livers of HBx-transgenic mice and specimens obtained from HCC patients to compare with the corresponding control. Our data suggest that the physical interaction of HBx and PARP1 accelerates DNA damage by inhibiting recruitment of the DNA repair complex to the damaged DNA sites, which may lead to the onset of hepatocarcinogenesis.
乙型肝炎病毒 X 蛋白 (HBx) 通过蛋白-蛋白相互作用调节许多宿主或病毒蛋白的活性,从而促进肝细胞癌 (HCC) 的发展。在这项研究中,我们使用蛋白质组学方法鉴定了多聚(ADP-核糖)聚合酶 (PARP1),一种 DNA 修复的关键因子,作为 HBx 的相互作用蛋白。共免疫沉淀和邻近连接测定证实了 HBx 和 PARP1 在核内的结合和共定位。HBx 蛋白的羧基末端与 PARP1 的催化结构域结合,这种结合降低了 PARP1 在体外和体内测定中的酶活性。HBx 中断了 PARP1 与 Sirt6 的结合,Sirt6 催化 DNA 修复所需的单 ADP-核糖基化。一致地,HBx 的过表达抑制了 Chang 肝细胞在氧化应激下产生的 γH2AX DNA 修复焦点的清除。在存在 HBx 的情况下,通过激光微照射测定和损伤特异性染色质免疫沉淀测定,抑制了 DNA 修复复合物向特定双链断裂的募集。结果,HBx 增加了 DNA 损伤的迹象,如 8-羟基-2'-脱氧鸟苷的积累和彗星形成,而过表达 PARP1 和/或 Sirt6 可逆转这些迹象。最后,与相应的对照相比,HBx 转基因小鼠肝脏和 HCC 患者标本中 PARP1 和 Sirt6 之间的相互作用明显降低。我们的数据表明,HBx 和 PARP1 的物理相互作用通过抑制 DNA 修复复合物向受损 DNA 位点的募集加速了 DNA 损伤,这可能导致肝癌的发生。